Operating Lease, Liability, Noncurrent of BIO-RAD LABORATORIES, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
BIO-RAD LABORATORIES, INC. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • BIO-RAD LABORATORIES, INC. Operating Lease, Liability, Noncurrent for the quarter ending 30 Sep 2025 was $155,800,000, a 8.3% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $155,800,000 +$11,881,000 +8.3% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $164,800,000 +$13,825,000 +9.2% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $126,300,000 -$33,514,000 -21% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $131,400,000 -$34,100,000 -21% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $143,919,000 -$23,260,000 -14% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $150,975,000 +$4,126,000 +2.8% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $159,814,000 +$12,774,000 +8.7% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $165,500,000 +$11,903,000 +7.8% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $167,179,000 +$19,968,000 +14% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $146,849,000 -$11,680,000 -7.4% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $147,040,000 -$22,694,000 -13% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $153,597,000 -$22,341,000 -13% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $147,211,000 -$29,607,000 -17% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $158,529,000 -$5,385,000 -3.3% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $169,734,000 +$1,408,000 +0.84% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $175,938,000 +$810,000 +0.46% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $176,818,000 +$4,674,000 +2.7% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $163,914,000 -$9,189,000 -5.3% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $168,326,000 -$7,126,000 -4.1% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $175,128,000 -$890,000 -0.51% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $172,144,000 -$20,456,000 -11% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $173,103,000 -$14,588,000 -7.8% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $175,452,000 -$17,106,000 -8.9% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $176,018,000 +$176,018,000 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $192,600,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $187,691,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $192,558,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.